✦ LIBER ✦

Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis

✍ Scribed by Piercarlo Sarzi-Puttini; Marco Cazzola; Benedetta Panni; Maurizio Turiel; Tania Fiorini; Nebiat Belai-Beyene; Enrico Chèrié-Lignièré

Publisher: Springer
Year: 2002
Tongue: English
Weight: 83 KB
Volume: 21
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-001-0166-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose methotrexate treatment of rheum

Low-dose methotrexate treatment of rheumatoid arthritis; Long-term observation of efficacy and safety

✍ E. Szanto 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 449 KB

Clinical and histological improvement wi

Clinical and histological improvement with long-term, low-dose cyclosporin A in a patient with severe IgA nephropathy

✍ M. Kobayashi; Y. Kobayashi; N. Kobayashi; H. Tanaka; T. Sano; T. Tagawa 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 374 KB

Long-term low-dose cyclosporin A in ster

Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood

✍ T. J. Neuhaus; H. R. Burger; M. Klingler; A. Fanconi; E. P. Leumann 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 412 KB

Long-term safety and efficacy of abatace

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

✍ Nicolino Ruperto; Daniel J. Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pé 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Long-term prospective trial of low-dose

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

✍ Michael E. Weinblatt; David E. Trentham; Patricia A. Fraser; Donald E. Holdswort 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

Long-term safety and efficacy of etanerc

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye